Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Plos Computational Biology
|
August 26, 2016
Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors
Danika Lindsay, Colleen M Garvey, Shannon M Mumenthaler, et al.
Genetics
|
March 17, 2011
Intratumor heterogeneity in evolutionary models of tumor progression
Rick Durrett, Jasmine Foo, Kevin Leder, et al.
Theoretical Population Biology
|
May 22, 2010
Evolutionary dynamics of tumor progression with random fitness values
Rick Durrett, Jasmine Foo, Kevin Leder, et al.
Plos Computational Biology
|
September 15, 2009
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib
Jasmine Foo, Mark W Drummond, Bayard Clarkson, et al.
Plos Computational Biology
|
October 21, 2016
Optimized Treatment Schedules for Chronic Myeloid Leukemia
Qie He, Junfeng Zhu, David Dingli, et al.
Haematologica
|
March 16, 2012
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials
Min Tang, Jasmine Foo, Mithat Gönen, et al.
Plos One
|
December 6, 2011
Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia
Kevin Leder, Jasmine Foo, Brian Skaggs, et al.
NPJ Systems Biology and Applications
|
February 6, 2025
Modeling critical dosing strategies for stromal-induced resistance to cancer therapy
Anna K Kraut, Colleen M Garvey, Carly Strelez, et al.
Cancer Research
|
December 4, 2016
Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach
Marc D Ryser, Walter T Lee, Neal E Ready, et al.
Plos Computational Biology
|
September 18, 2015
An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer
Jasmine Foo, Lin L Liu, Kevin Leder, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Plos Computational Biology
|
August 26, 2016
Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors
Danika Lindsay, Colleen M Garvey, Shannon M Mumenthaler, et al.
Genetics
|
March 17, 2011
Intratumor heterogeneity in evolutionary models of tumor progression
Rick Durrett, Jasmine Foo, Kevin Leder, et al.
Theoretical Population Biology
|
May 22, 2010
Evolutionary dynamics of tumor progression with random fitness values
Rick Durrett, Jasmine Foo, Kevin Leder, et al.
Plos Computational Biology
|
September 15, 2009
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib
Jasmine Foo, Mark W Drummond, Bayard Clarkson, et al.
Plos Computational Biology
|
October 21, 2016
Optimized Treatment Schedules for Chronic Myeloid Leukemia
Qie He, Junfeng Zhu, David Dingli, et al.
Haematologica
|
March 16, 2012
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials
Min Tang, Jasmine Foo, Mithat Gönen, et al.
Plos One
|
December 6, 2011
Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia
Kevin Leder, Jasmine Foo, Brian Skaggs, et al.
NPJ Systems Biology and Applications
|
February 6, 2025
Modeling critical dosing strategies for stromal-induced resistance to cancer therapy
Anna K Kraut, Colleen M Garvey, Carly Strelez, et al.
Cancer Research
|
December 4, 2016
Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach
Marc D Ryser, Walter T Lee, Neal E Ready, et al.
Plos Computational Biology
|
September 18, 2015
An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer
Jasmine Foo, Lin L Liu, Kevin Leder, et al.
Page
of 5